Nutra Nano Tech to launch the CholZero™ product line in the United States

06/03/06 Eugene Science, Inc. has announced that Nutra Nano Tech, Inc., a product marketing and distribution company headquartered in Los Angeles, California, placed an initial production order with Eugene Science to launch the "CholZero™" product line in the United States. Eugene Science expects Nutra Nano Tech to launch the CholZero™ product line in the United States in April 2006.

Nutra Nano Tech recently completed an 8-week independent research study in the United States on CholZero™ and its cholesterol-lowering effects. Participants in the research study were instructed not to change anything about their lifestyle and diet other than to take CholZero™ capsules as directed for a period of 60 days. The research study revealed that participants using the CholZero™ capsules, on average, saw their total blood cholesterol levels drop by 19%, their LDL, or "bad cholesterol," levels drop by 35%, their HDL, or "good cholesterol," levels increase by 43%, and their triglyceride levels drop by 48%.

Nutra Nano Tech is a product marketing and distribution company focused on the direct response industry. Nutra Nano Tech owns the exclusive license for the CholZero™ product line in the North American market.

Eugene Science is a global biotechnology company focused on tackling ailments such as heart disease, obesity and diabetes though technological innovations and product developments in the nutraceutical field. As a first commercialization project against heart disease, Eugene Science has developed a nanoscience-based product called CZ™, a cholesterol-lowering functional food ingredient for health-conscious consumers. Eugene Science intends to license its "CZ Series" brand of cholesterol-lowering ingredients to companies worldwide. Eugene Science is headquartered in Bucheon, Kyunggi-Do, Korea, and was founded July 1997.

http://www.marketwire.com/mw/release_html_b1?release_id=111763